0000950170-24-042010.txt : 20240404
0000950170-24-042010.hdr.sgml : 20240404
20240404201335
ACCESSION NUMBER: 0000950170-24-042010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
ORGANIZATION NAME:
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 24824478
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH TARGET N V
CENTRAL INDEX KEY: 0001259870
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 24824479
MAIL ADDRESS:
STREET 1: ARA HILL TOP BUILDING, UNIT A-5
STREET 2: PLETTERIJWEG OOST 1, CURACAO
CITY: WILLEMSTAD
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
ownership.xml
4
X0508
4
2024-04-02
0001183765
Molecular Templates, Inc.
MTEM
0001259870
BIOTECH TARGET N V
ARA HILL TOP BUILDING, UNIT A-5,
PLETTERIJWEG OOST 1
CURACAO
P8
00000
NETHERLANDS ANTILLES
false
false
true
false
0000924223
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
CH-8200
SWITZERLAND
false
false
true
false
false
Common Stock
2024-04-02
4
P
false
250000
2.35
A
1279820
D
Prefunded Warrants (right to buy)
0.001
2024-04-02
4
P
false
134667
2.349
A
2024-04-02
2029-04-02
Common Stock
134667
134667
D
Common Warrants (right to buy)
2.35
2024-04-02
4
P
false
769334
0.125
A
2024-04-02
Common Stock
769334
769334
D
The Common Warrants have a term of five years and the Prefunded Warrants will expire when fully exercised in accordance with their terms. The Prefunded and Common Warrants may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed 19.99% of the number of the shares of Common Stock outstanding immediately following such exercise.
Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.
By: /s/Ivo Betschart
2024-04-04
By: /s/ Martin Gubler
2024-04-04